Administration of oral azithromycin, in addition to previously well-tolerat
ed long-term amiodarone therapy, was associated with a marked prolongation
of QT interval and increased QT dispersion, both substrates for life-threat
ening ventricular tachyarrhythmia and torsades de pointes. This is a report
of QT prolongation and increased QT dispersion associated with the use of
azithromycin. The report assumes an added significance, in view of widespre
ad empirical use of this antibiotic for the treatment of lower respiratory
infections and belief of its safety in patients with cardiac diseases. Base
d on the authors' experience, they would like to emphasize that the combina
tion of azithromycin with other drugs known to prolong QT or causing torsad
es de pointes be used with caution until the question of the proarrhythmic
effect of azithromycin is resolved by further studies.